DANIEL MIRDA, M.D.
Hematology & Oncology Physician · NAPA, CA
Individual Active NPI 1811963317
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 461 | 57,686 | $2,572,361 | $853,871 | $666,585 |
| 2023 | 443 | 53,713 | $1,844,582 | $759,127 | $590,346 |
| 2022 | 484 | 42,661 | $1,511,197 | $606,380 | $474,654 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 20,180 | $3 | $2 |
| J0897 | Injection, denosumab, 1 mg | 5,220 | $26 | $20 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 810 | $203 | $152 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 565 | $18 | $14 |
| 96372 | Injection of drug or substance under skin or into muscle | 284 | $17 | $13 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 201 | $144 | $101 |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | 145 | $145 | $110 |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $178 | $142 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 62 | $123 | $97 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 60 | $84 | $67 |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 58 | $43 | $34 |
| 99205 | New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 49 | $246 | $169 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | G57247 | CA |
| Hematology (Internal Medicine) Physician | 207RH0000X | G57247 | CA | |
| Medical Oncology Physician | 207RX0202X | G57247 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in California
- NPI 1992770069
- NPI 1386731693
- NPI 1275827941
- NPI 1720200363
- NPI 1801076633
- NPI 1619473667
- NPI 1043509797
- NPI 1982165213
See all Hematology & Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.